Copyright: Immunotech Applied Science Limited   京ICP备19008112号-1    
About
Overview
Team
History
Branch
Honor
Culture
Science and product
R & D Platform
Product Pipelines
Product introduction
Patient area
Past research
Patient recruitment
News
Company news
Industry news
Investor Relations
Prospectus
Financial Report
Announcements and Circulars
Corporate Governance
Investor Inquiry
Cooperation
Cooperation
Careers
Talent Strategy
Campus Recruiting
Social recruitment
Contact
Contact
Messages
Prospectus

Prospectus
Financial Report

Financial Report
Announcement & Circular

Announcement & Circular
Corporate Governance

Corporate Governance
Investor Inquiry

Investor Inquiry

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
2023-12-04
Classification:
Announcement & Circular
File size:
65KB
Download

RECEIPT OF THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATIONFOR THE aT19 INJECTION
2023-11-24
Classification:
Announcement & Circular
File size:
92KB
Download

FIRST PATIENT ENROLLED IN THE PHASE I CLINICAL TRIAL FOR THE DENOCABTAGENE CILOLEUCEL INJECTION
2023-11-07
Classification:
Announcement & Circular
File size:
187KB
Download

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
2023-11-03
Classification:
Announcement & Circular
File size:
65KB
Download

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
2023-10-06
Classification:
Announcement & Circular
File size:
65KB
Download

EAL WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR TREATMENT OF LIVER CANCER BY THE CENTER FOR DRUG EVALUATION
2023-09-05
Classification:
Announcement & Circular
File size:
98KB
Download

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
2023-09-05
Classification:
Announcement & Circular
File size:
65KB
Download

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
2023-08-27
Classification:
Announcement & Circular
File size:
84KB
Download
Page up
1
2
...
18